## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors present ISPRED-SEQ, a method combining protein language model embeddings and deep neural networks to predict protein-protein interaction sites from sequence alone. They claim the method outperforms state-of-the-art predictors for the same task and is freely available as a web service.
- **Visible evidence base** Abstract text only; no quantitative results, benchmark details, or methodological specifics are provided
- **Missing materials affecting confidence** Full manuscript, all figures and tables, benchmark datasets, evaluation metrics, comparison protocols, and supplementary information

## Reviewer
- **Overall assessment** The abstract presents a potentially useful contribution to the field of protein-protein interaction site prediction, addressing a relevant problem given the gap between sequence and structure availability. However, the abstract lacks quantitative evidence, methodological detail, and benchmark context necessary to evaluate the central claim of outperforming state-of-the-art predictors. The contribution cannot be assessed from the supplied material alone.
- **Who would be interested in the results, and why** Computational biologists and bioinformaticians working on protein function annotation, protein-protein interaction prediction, and applications of protein language models. Researchers developing deep learning methods for biological sequence analysis would also find the approach relevant, particularly those interested in transfer learning from language model embeddings.
- **Major strengths** The problem addressed is timely and important, given the growing gap between sequence and structure data. The use of protein language model embeddings is a current and promising direction. The stated availability of a free web service is a practical strength for community adoption.
- **Major Concerns** 
  - **Concern ID** R1-M1
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Evidence sufficiency
  - **Claim pointer** The abstract claims ISPRED-SEQ "overpasses state-of-the-art predictors addressing the same problem"
  - **Evidence pointer** Abstract text; location not provided
  - **Concern** The central performance claim is presented without any quantitative support. No metrics, benchmark datasets, comparison methods, or statistical significance measures are reported in the abstract.
  - **Why it matters** The claim of outperforming state-of-the-art predictors is the primary scientific contribution of the work. Without quantitative evidence, the claim cannot be verified or contextualized, and the reader cannot assess whether the improvement is meaningful or marginal.
  - **Resolution test** Provide performance metrics (e.g., AUC, precision, recall, F1) on standard benchmark datasets, with explicit comparison to named state-of-the-art methods, including statistical significance testing where appropriate.
  - **Concern ID** R1-M2
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Methodological transparency
  - **Claim pointer** The abstract describes ISPRED-SEQ as combining "recently developed protein language models and Deep Neural networks"
  - **Evidence pointer** Abstract text; location not provided
  - **Concern** The abstract provides no details on the architecture, training data, embedding choice, or model selection process. The methodological description is too vague to allow replication or even informed evaluation.
  - **Why it matters** Reproducibility is a core requirement for computational biology methods. Without architectural and training details, the method cannot be independently implemented or compared, and the scientific value of the contribution is substantially diminished.
  - **Resolution test** Include in the full manuscript a complete description of the model architecture, hyperparameters, training and validation splits, embedding model and version, and any feature engineering steps.
  - **Concern ID** R1-M3
  - **Severity** Major
  - **Blocking** Yes
  - **Axis** Benchmark validity
  - **Claim pointer** The abstract implies the method is evaluated against existing predictors, but no evaluation protocol is described
  - **Evidence pointer** Abstract text; location not provided
  - **Concern** No information is given about the datasets used for training and testing, the definition of interaction sites, the granularity of prediction (residue-level versus segment-level), or the evaluation protocol. Potential issues such as sequence redundancy, homology leakage, or class imbalance are not addressed.
  - **Why it matters** Benchmark design critically affects the validity of performance claims. Without clarity on these points, the reported superiority could be an artifact of dataset construction or evaluation choices rather than genuine methodological advance.
  - **Resolution test** Describe the datasets, their sources, redundancy filtering procedures, and evaluation metrics in the full manuscript. Provide evidence that the benchmark is unbiased and comparable to those used by prior methods.
- **Minor Comments** 
  - **Concern ID** R1-m1
  - **Severity** Minor
  - **Axis** Clarity
  - **Affected element** Title and terminology
  - **Evidence pointer** Abstract text
  - **Issue** The term "interaction sites" is used without specifying whether this refers to residues directly involved in binding, interface regions, or other definitions. This ambiguity could confuse readers and complicate comparisons with other methods.
  - **Required correction** Define "interaction sites" explicitly in the abstract or full manuscript, and state how this definition aligns with or differs from prior work.
  - **Concern ID** R1-m2
  - **Severity** Minor
  - **Axis** Accessibility
  - **Affected element** Web service availability
  - **Evidence pointer** Abstract text
  - **Issue** The abstract states the tool is "freely available for testing" but does not mention whether the source code, trained models, or benchmark datasets are also available. This limits reproducibility and community adoption.
  - **Required correction** State in the abstract or full manuscript the availability of source code, trained models, and datasets, with appropriate licenses and access conditions.
  - **Concern ID** R1-m3
  - **Severity** Minor
  - **Axis** Contextualization
  - **Affected element** Related work
  - **Evidence pointer** Abstract text
  - **Issue** The abstract does not name any specific prior predictors or describe the landscape of existing methods. This makes it difficult to understand the incremental contribution.
  - **Required correction** Briefly mention representative existing methods and their limitations in the abstract or full manuscript, and clearly state what ISPRED-SEQ adds beyond them.
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3. The abstract provides no quantitative results, no methodological detail, and no benchmark description. The central claims of the work cannot be evaluated from the supplied material.

## Risk / unsupported claims
- The claim that ISPRED-SEQ "overpasses state-of-the-art predictors" is unsupported in the abstract due to absence of any quantitative comparison.
- The implied methodological novelty of combining protein language models with deep neural networks is not assessable without architectural details.
- The generalizability of the method across different protein families or interaction types is not addressed and cannot be inferred from the abstract.
- The practical utility of the web service cannot be evaluated without information on input requirements, output format, and processing capacity.

## Assessment against Nature-style criteria
- **Originality** Not assessable from the abstract. The combination of language model embeddings with deep networks for PPI site prediction is plausible but not demonstrably novel without comparison to existing methods and clear articulation of the new contribution.
- **Scientific importance** The problem is important, and the abstract states a relevant motivation. However, the significance of the specific contribution cannot be established without quantitative evidence of improvement over existing methods.
- **Interdisciplinary readership** The abstract is written in a way that is accessible to a broad computational biology audience, but the lack of methodological detail limits its usefulness to specialists and nonspecialists alike.
- **Technical soundness** Not assessable. No technical details, evaluation metrics, or benchmark results are provided in the abstract.
- **Readability for nonspecialists** The abstract is concise and readable, but the vague terminology and absence of results reduce its informative value for nonspecialist readers.

## Recommendation posture
Currently not established from the provided evidence. The abstract presents a plausible and potentially useful contribution, but the central claims are unsupported by quantitative data or methodological detail. A decision on the manuscript requires access to the full text, including benchmark results, model architecture, and evaluation protocols. If the full manuscript provides solid evidence for the performance claims and methodological soundness, the work could be of interest to the computational biology community.